Yongyu Yang

发表

Based on the Beers Criteria 2019 Edition Over-the-Counter Drugs Risk Confirmation of Elderly Chinese

Shusen Sun, Yongyu Yang, Lu Zhang, 2021, BioMed research international.

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma

Yongyu Yang, Heping Kan, Lei Gao, 2022, Bioengineered.

LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-kB Pathway

Yaomin Li, Bowen Ni, Hai Wang, 2022, Frontiers in Oncology.

Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis

Weijun Peng, Yongyu Yang, Fen Li, 2022, Drug design, development and therapy.

Chemical constituents of Morus alba L. and their inhibitory effect on 3T3-L1 preadipocyte proliferation and differentiation.

Changping Hu, Yongyu Yang, Yingjun Zhou, 2014, Fitoterapia.

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma

Yongyu Yang, Heping Kan, Lei Gao, 2022, Journal of immunology research.

Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years

Junyong Wu, Xinyan Hao, Daxiong Xiang, 2022, Frontiers in Pharmacology.

Genetic insights unraveling quorum quenching potential of indigenous isolates from an anaerobic membrane bioreactor.

Yeyuan Xiao, H. Waheed, C. T. Mehmood, 2021, The Science of the total environment.

Dynamics of biofilms on different polymeric membranes – A comparative study using five physiologically and genetically distinct bacteria

Yeyuan Xiao, W. Tan, H. Waheed, 2022, Journal of Membrane Science.

Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation

Yongyu Yang, Jun-Ying Chen, Yuanhua Liu, 2020, World Journal of Surgical Oncology.